Showing results (11-20 of 154) with videos related to
Sort By:
Pageof 16
Pflugers Archiv : European Journal of Physiology|November 21, 2018
Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathyAmelia A Glazier, Andrea Thompson, Sharlene M DaySports Health|September 28, 2012
Cardiovascular health, part 2: sports participation in athletes with cardiovascular conditionsTimir S Baman, Sanjaya Gupta, Sharlene M DayProgress in Cardiovascular Diseases|August 25, 2023
Patient-reported outcomes in clinical studies of patients with hypertrophic cardiomyopathyNosheen Reza, Sharlene M Day, Anjali Tiku OwensJCI Insight|June 8, 2018
HSC70 is a chaperone for wild-type and mutant cardiac myosin binding protein CAmelia A Glazier, Neha Hafeez, Dattatreya Mellacheruvu, et al.Journal of Molecular Medicine (Berlin, Germany)|March 31, 2007
Tuning cardiac performance in ischemic heart disease and failure by modulating myofilament functionSharlene M Day, Margaret V Westfall, Joseph M MetzgerThe Journal of Clinical Investigation|March 1, 2022
Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failureSharlene M Day, Jil C Tardiff, E Michael OstapBiorxiv : the Preprint Server for Biology|June 22, 2026
Pathogenic MYBPC3 missense variants alter protein-protein interactions within the sarcomereAndrea D Thompson, Chelsea Pankiewicz, Lucy S Plenge, et al.JACC. Case Reports|July 28, 2021
Applying Shared Decision Making to Sports Participation for a Patient With Hypertrophic CardiomyopathyAlejandro E de Feria, Kimberly Y Lin, Sharlene M DayAmerican Journal of Cardiovascular Disease|June 21, 2013
Prevalence of aortic dilation in hypertrophic cardiomyopathyRenuka Jain, Adam Helms, Sharlene M Day, et al.Pageof 16